Colin Walsh

Colin Walsh

Director/Board Member at ATTOVIA THERAPEUTICS, INC.
40 year
Health Technology
Finance
Electronic Technology

Profile

Colin Walsh is currently Director at Ceptur Therapeutics, Inc., Managing Director-Life Sciences Investing at The Goldman Sachs Group, Inc. since 2023, Director at Vicebio Ltd. since 2024, Independent Director at Attovia Therapeutics, Inc. since 2024, and Board Member at Element Science, Inc. since 2019.
Former roles include Independent Director at Elevation Oncology, Inc. from 2019 to 2023, Vice President at NanoDimension, Inc., Partner at Qiming US Ventures Management, LLC from 2020 to 2023, Senior Associate at NanoDimension Management Ltd., Principal at Precision NanoSystems, Inc., and Board Member at Korro Bio, Inc. (United States) from 2020 to 2023.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Massachusetts Amherst.

Colin Walsh active positions

CompaniesPositionStart
ATTOVIA THERAPEUTICS, INC. Director/Board Member 01/05/2024
THE GOLDMAN SACHS GROUP, INC. Corporate Officer/Principal 01/09/2023
Director/Board Member -
Director/Board Member 01/08/2019
Director/Board Member 01/09/2024

Former positions of Colin Walsh

CompaniesPositionEnd
Private Equity Investor 31/10/2023
ELEN ONCO Director/Board Member 21/09/2023
Director/Board Member 01/09/2023
Corporate Officer/Principal -
░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░ -
See the detail of Colin Walsh's experience

Training of Colin Walsh

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Finance

Electronic Technology

Consumer Services

Finance

Finance

Electronic Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology